ARCTURUS THERAPEUTICS HOLDINARCT
ASignal's systematic analysis rates ARCT as Bearish.
Reflects the latest available analysis · analyzed Oct 5, 2026
The case on ARCT
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong cash position with $191.48M cash on balance sheet
- Low debt-to-equity ratio of 0.13x indicating minimal leverage risk
- Current ratio of 5.88x suggests strong short-term liquidity
- MACD histogram showing contraction, potentially nearing oversold reversal
- Negative operating and gross margins (operating margin: -863.30%, gross margin: -195.50%)
- Severe year-over-year revenue decline of -89.50%
- Negative return on equity (-46.31%) and return on assets (-23.96%)
- Overvalued metrics: EV/EBITDA at -2.03x, forward P/E at -3.59x
- High price-to-sales ratio of 12.61x despite negative growth
- Price below 20-day and 50-day moving averages indicating downtrend
See the full verdict on ARCT
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes ARCT
Most investors never get a second opinion, let alone several. ASignal runs ARCT past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.